Quality of life in older French long-term lung cancer survivors: VICAN5 national survey.

[1]  E. Philip,et al.  Fear of Cancer Recurrence or Progression: What Is It and What Can We Do About It? , 2022, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[2]  N. Girard,et al.  Targeted Therapy for Older Patients with Non-Small Cell Lung Cancer: Systematic Review and Guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)/French-Language Oncology Group (GOLF) , 2022, Cancers.

[3]  H. Tesch,et al.  Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin , 2021, Supportive Care in Cancer.

[4]  P. Butow,et al.  Disability, psychological distress and quality of life in relation to cancer diagnosis and cancer type: population-based Australian study of 22,505 cancer survivors and 244,000 people without cancer , 2020, BMC Medicine.

[5]  M. Izquierdo,et al.  Effects of a Multicomponent Exercise Program in Older Adults with Non-Small-Cell Lung Cancer during Adjuvant/Palliative Treatment: An Intervention Study , 2020, Journal of clinical medicine.

[6]  M. Lanza,et al.  Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled? , 2019, The oncologist.

[7]  M. Clark,et al.  Spirituality and Emotional Distress Among Lung Cancer Survivors. , 2019, Clinical lung cancer.

[8]  G. Shukla,et al.  A Randomized Controlled Trial to Assess the Effectiveness of Muscle Strengthening and Balancing Exercises on Chemotherapy-Induced Peripheral Neuropathic Pain and Quality of Life Among Cancer Patients , 2019, Cancer nursing.

[9]  M. Blettner,et al.  Quality of Life in NSCLC Survivors — A Multicenter Cross‐Sectional Study , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  Moon Soo Kim,et al.  Comparison of fatigue, depression, and anxiety as factors affecting posttreatment health‐related quality of life in lung cancer survivors , 2018, Psycho-oncology.

[11]  N. Staff,et al.  Chemotherapy‐induced peripheral neuropathy: A current review , 2017, Annals of neurology.

[12]  P. Verger,et al.  Comparison of pharmacy‐based and diagnosis‐based comorbidity measures from medical administrative data , 2017, Pharmacoepidemiology and drug safety.

[13]  L. Huiart,et al.  Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey , 2017, Journal of Cancer Survivorship.

[14]  M. Annunziata,et al.  Posttraumatic growth and cancer: a study 5 years after treatment end , 2016, Supportive Care in Cancer.

[15]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[16]  B. Milleron,et al.  Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients. , 2016, European journal of cancer.

[17]  Hwasoon Kim,et al.  Post-traumatic growth in stomach cancer survivors: Prevalence, correlates and relationship with health-related quality of life. , 2015, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[18]  M. Bendiane,et al.  The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey) , 2015, BMJ Open.

[19]  D. Hemsworth,et al.  Reliability and Validity of a French Version of the Posttraumatic Growth Inventory , 2015 .

[20]  S. Chambers,et al.  Psychological wellness and health-related stigma: a pilot study of an acceptance-focused cognitive behavioural intervention for people with lung cancer , 2014, European journal of cancer care.

[21]  H. Sintonen,et al.  Long-term lung cancer survivors have permanently decreased quality of life after surgery. , 2015, Clinical lung cancer.

[22]  David R. Jones,et al.  Comprehensive long-term care of patients with lung cancer: development of a novel thoracic survivorship program. , 2014, The Annals of thoracic surgery.

[23]  A. Roughley,et al.  The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study , 2013, Supportive Care in Cancer.

[24]  M. Clark,et al.  Quality of Life and Symptom Burden among Long-Term Lung Cancer Survivors , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[25]  E. Coups,et al.  Fatigue and functional impairment in early-stage non-small cell lung cancer survivors. , 2010, Journal of pain and symptom management.

[26]  P. Lambin,et al.  Health-related quality of life in patients surviving non-small cell lung cancer , 2010, Thorax.

[27]  A. Weill,et al.  French national health insurance information system and the permanent beneficiaries sample. , 2010, Revue d'epidemiologie et de sante publique.

[28]  E. Coups,et al.  Current Dyspnea Among Long-Term Survivors of Early-Stage Non-small Cell Lung Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[29]  B. Powers,et al.  Can this patient read and understand written health information? , 2010, JAMA.

[30]  R. Hays,et al.  Impact of cancer on health-related quality of life of older Americans. , 2009, Journal of the National Cancer Institute.

[31]  J. Savard,et al.  Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence , 2009, Supportive Care in Cancer.

[32]  A. Bezjak,et al.  Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  P. Ganz,et al.  The impact of cancer and quality of life for long‐term survivors , 2008, Psycho-oncology.

[34]  M. King,et al.  Quality of life and survival in the 2 years after surgery for non small-cell lung cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  M. Sharpe,et al.  Clinically relevant fatigue in cancer outpatients: the Edinburgh Cancer Centre symptom study. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[36]  Benjamin Littenberg,et al.  The Single Item Literacy Screener: Evaluation of a brief instrument to identify limited reading ability , 2006, BMC family practice.

[37]  Jean-Louis Lanoë,et al.  L'état de santé en France en 2003 : santé perçue, morbidité déclarée et recours aux soins à travers l'enquête décennale santé , 2005 .

[38]  Bernard Laurent,et al.  Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) , 2005, Pain.

[39]  F. Grannis,et al.  Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. , 2004, Chest.

[40]  M. Brecht,et al.  Quality of life of long-term survivors of non-small-cell lung cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Penny Hopwood,et al.  A body image scale for use with cancer patients. , 2001, European journal of cancer.

[42]  M. Felix,et al.  The SF-12 as a population health measure: an exploratory examination of potential for application. , 2000, Health services research.

[43]  N. Aaronson,et al.  Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. , 1997, Journal of clinical epidemiology.

[44]  R. Tedeschi,et al.  The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. , 1996, Journal of traumatic stress.

[45]  H. Kreisman,et al.  Long-term postthoracotomy pain. , 1991, Chest.

[46]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[47]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.